Prostatis Group Portfolio holdings
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 5.73% |
| 2 | Healthcare | 4.76% |
| 3 | Consumer Discretionary | 3.12% |
| 4 | Communication Services | 2.79% |
| 5 | Financials | 1.38% |
Similar funds
Prostatis Group's Q2 2020 Portfolio in Review
As of Q2 2020, Prostatis Group held 81 positions worth $49.7M, down 29% from $70.4M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Prostatis Group withdrew a net $25.9M in Q2 2020, closing 18 positions and reducing 11 holdings. Its most notable exit was abrdn Physical Palladium Shares ETF, an estimated $9.03M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 2.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Prostatis Group opened a new position in iShares MSCI USA Momentum Factor ETF worth $4.01M.
- Prostatis Group's largest Q2 2020 buy was iShares MSCI USA Momentum Factor ETF: 30,588 shares worth $4.01M.
- Prostatis Group added most to iShares MSCI USA Min Vol Factor ETF in Q2 2020, an estimated $3.7M increase.
- Prostatis Group's biggest Q2 2020 reduction was abrdn Physical Gold Shares ETF, cutting an estimated $7.54M.
- Prostatis Group fully exited abrdn Physical Palladium Shares ETF in Q2 2020, selling an estimated $9.03M.
- Prostatis Group's ten largest holdings make up 43% of its $49.7M portfolio in Q2 2020.
- Prostatis Group opened 24 new positions and closed 18 in Q2 2020.
- Prostatis Group's portfolio value fell 29% quarter-over-quarter to $49.7M.
Based on Prostatis Group's 13F filing for Q2 2020, filed 23 Mar 2023.